ATE331729T1 - Tetrapeptidische tryptase substrate und ihre verwendung zur tryptase aktivitätbestimmung - Google Patents

Tetrapeptidische tryptase substrate und ihre verwendung zur tryptase aktivitätbestimmung

Info

Publication number
ATE331729T1
ATE331729T1 AT01988724T AT01988724T ATE331729T1 AT E331729 T1 ATE331729 T1 AT E331729T1 AT 01988724 T AT01988724 T AT 01988724T AT 01988724 T AT01988724 T AT 01988724T AT E331729 T1 ATE331729 T1 AT E331729T1
Authority
AT
Austria
Prior art keywords
tryptase
substrates
seq
tetrapeptidic
determining
Prior art date
Application number
AT01988724T
Other languages
English (en)
Inventor
Andrew L Niles
Mary Haak-Frendscho
Jennifer L Harris
Charles S Craik
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Application granted granted Critical
Publication of ATE331729T1 publication Critical patent/ATE331729T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT01988724T 2000-10-27 2001-10-03 Tetrapeptidische tryptase substrate und ihre verwendung zur tryptase aktivitätbestimmung ATE331729T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24401300P 2000-10-27 2000-10-27
US09/955,639 US6797461B2 (en) 2000-10-27 2001-09-19 Tryptase substrates and assay for tryptase activity using same

Publications (1)

Publication Number Publication Date
ATE331729T1 true ATE331729T1 (de) 2006-07-15

Family

ID=26936256

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01988724T ATE331729T1 (de) 2000-10-27 2001-10-03 Tetrapeptidische tryptase substrate und ihre verwendung zur tryptase aktivitätbestimmung

Country Status (6)

Country Link
US (1) US6797461B2 (de)
EP (1) EP1358205B1 (de)
AT (1) ATE331729T1 (de)
AU (1) AU2002216613A1 (de)
DE (1) DE60121225T2 (de)
WO (1) WO2002034765A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200502867B (en) * 2002-10-02 2007-09-26 Catalyst Biosciences Inc Methods of generating and screening for proteases with altered specificity
US7416854B2 (en) * 2004-01-22 2008-08-26 Promega Corporation Luminogenic and nonluminogenic multiplex assay
EP3309556B1 (de) 2009-06-25 2020-04-08 Prometheus Biosciences, Inc. Verfahren zur diagnostizierung des reizdarmsyndroms
US20220364141A1 (en) * 2019-09-05 2022-11-17 National University Corporation Tokyo University Of Agriculture And Technology Tryptase Activity Measurement Substrate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL60888A (en) * 1978-06-16 1984-07-31 Yeda Res & Dev Substrates and process for the quantitative assay of enzymes
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
SE453510B (sv) 1980-12-29 1988-02-08 Toyo Jozo Kk Peptid for analys av humant paratyroidhormon
US4390528A (en) 1981-11-16 1983-06-28 Research Corporation Tuftsinyl-tuftsin
US5391705A (en) 1991-03-15 1995-02-21 Merrell Dow Pharmaceuticals Inc. Polyfluorinated tripeptide thrombin inhibitors
US5589458A (en) * 1992-11-13 1996-12-31 Thomas Jefferson University Compounds that inhibit T cell proliferation and methods for using the same
GB2324529A (en) 1997-02-21 1998-10-28 Merck & Co Inc A combinatorial library based on a tetrapeptide substituted with aminomethylcoumarin for characterizing proteases
EP0980440B1 (de) * 1997-05-01 2007-08-01 Minnesota Mining And Manufacturing Company Fluorogene protease-substrate basierend auf farbstoffdimerisierung
AU3208500A (en) * 1999-01-27 2000-08-18 Ortho-Mcneil Pharmaceutical, Inc. Peptidyl heterocyclic ketones useful as tryptase inhibitors
CA2261326A1 (en) 1999-02-09 2000-08-09 Jean-Pascal Viola Laboratory cap and well for hanging-drop crystallization methods
US6680178B2 (en) 2000-06-02 2004-01-20 The Regents Of The University Of California Profiling of protease specificity using combinatorial fluorogenic substrate libraries

Also Published As

Publication number Publication date
US20020197661A1 (en) 2002-12-26
DE60121225T2 (de) 2007-05-31
EP1358205B1 (de) 2006-06-28
WO2002034765A9 (en) 2004-04-22
US6797461B2 (en) 2004-09-28
AU2002216613A1 (en) 2002-05-06
WO2002034765A2 (en) 2002-05-02
DE60121225D1 (de) 2006-08-10
EP1358205A2 (de) 2003-11-05
WO2002034765A3 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
DE69842027D1 (de) Mutanten der alpha-amylase
ATE536406T1 (de) Neuartiger zytokin-zcytor17-ligand
ATE346938T1 (de) Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
ATE271058T1 (de) Mycophenol bisphosponatverbindungen
ATE396993T1 (de) Tetrahydropyranyl-cyclopentyl- tetrahydropyridopyridin-modulatoren der chemokin- rezeptor-aktivität
ATE227739T1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
DE60235761D1 (de) Isoform des vegfs
AU2003275613A1 (en) Novel fructosyl peptide oxidase and utilization thereof
ATE462782T1 (de) Endothelstammzellen, populationen, isolierungsverfahren und verwendung davon
NZ514576A (en) Substituted 3-cyano-[1.7], [1.5], and [1.8]- naphthyridine inhibitors of tyrosine kinases
AU2002365646A1 (en) Novel proteins with il-6 inhibiting activity
ATE397077T1 (de) Substraten und nachweise zur wirksamkeit von beta-secretase
DE69813850D1 (de) Homogene nachweisverfahren zur bestimmung der phosphorylierungsaktivitäten von biologischem material
ATE331729T1 (de) Tetrapeptidische tryptase substrate und ihre verwendung zur tryptase aktivitätbestimmung
DE60210970D1 (de) Mutante formen von etxb und ctxb und ihre verwendung als träger
DK0942992T3 (da) O-fucosyltransferase
SE9401380D0 (sv) Ny celltillväxt-relaterad peptid och användning därav
NO994995D0 (no) Fremgangsmåte for identifisering av forbindelser for inhibering av neoplastiske lesjoner og farmasöytiske blandinger inneholdende slike forbindelser
ATE213742T1 (de) Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität
ATE458810T1 (de) Aggrecanase-1- und -2-peptidsubstrate und verfahren
ATE273394T1 (de) Wirts-vektor-systeme zur phosphatregulierten überproduktion von polypeptiden in bacillus
AU2002210533A1 (en) Identification of cytotoxic activity from the ink of aplysia punctata
ATE273792T1 (de) Verbundelemente enthaltend bitumen
WO2004096991A3 (en) Bcl2l12 polypeptide activators and inhibitors
ATE356872T1 (de) Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties